A SMOC2 variant inhibits BMP signaling by competitively binding to BMPR1B and causes growth plate defects

Area of Science:

• Skeletal Biology
• Molecular Genetics
• Developmental Biology

Background:

• Endochondral ossification is crucial for long bone development, with chondrogenesis as its final stage.
• Bone morphogenetic proteins (BMPs) are vital for chondrogenesis and growth plate regulation.
• Aberrant BMP signaling causes growth plate defects and osteochondrodysplasias.

Purpose of the Study:

• To investigate the pathophysiological mechanism of a SMOC2 mutation (c.1076 T > G) in vivo and in vitro.
• To elucidate the interaction between SMOC2 and the BMP-SMAD1/5/9 signaling pathway.
• To understand how SMOC2 mutations lead to skeletal abnormalities.

Main Methods:

• Generation of a mouse model with a knock-in SMOC2 mutation (c.1076 T > G).
• In vivo and in vitro analysis of the interaction between SMOC2 and BMP signaling.
• Assessment of growth plate morphology and cellularity in knock-in mice.

Main Results:

• The SMOC2 mutation resulted in short-limbed dwarfism and significant alterations in tibial growth plates.
• Mutant SMOC2 exhibited impaired binding to COL9A1 and HSPG.
• Mutant SMOC2 inhibited BMP signaling by competitively binding to BMPR1B, causing growth plate defects.

Conclusions:

• The SMOC2 mutation impairs its ability to bind COL9A1 and HSPG.
• Mutant SMOC2 disrupts BMP signaling by antagonizing BMPR1B, leading to osteochondrodysplasia.
• This study identifies a novel mechanism linking SMOC2 function to skeletal development and disease.